Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

Studie Overzicht

Toestand

Onbekend

Conditie

Gedetailleerde beschrijving

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

Studietype

Ingrijpend

Inschrijving (Verwacht)

80

Fase

  • Fase 4

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310009
        • Werving
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 70 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Dubbele

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
Placebo-vergelijker: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Postoperative pain score
Tijdsspanne: Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
Tijdsspanne: 1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
Tijdsspanne: 4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
Tijdsspanne: 8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
Tijdsspanne: 24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
Tijdsspanne: 48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Opioid requirement
Tijdsspanne: Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
Tijdsspanne: 1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
Tijdsspanne: 4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
Tijdsspanne: 8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
Tijdsspanne: 24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
Tijdsspanne: 48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
Tijdsspanne: 48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
Tijdsspanne: 48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
Tijdsspanne: before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
Tijdsspanne: after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
Tijdsspanne: immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
Tijdsspanne: before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
Tijdsspanne: after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
Tijdsspanne: immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
Tijdsspanne: before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
Tijdsspanne: after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
Tijdsspanne: immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
Tijdsspanne: before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
Tijdsspanne: after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
Tijdsspanne: immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
Tijdsspanne: before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
Tijdsspanne: after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
Tijdsspanne: immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
Tijdsspanne: before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
Tijdsspanne: after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
Tijdsspanne: immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
Tijdsspanne: from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Studie stoel: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Verwacht)

1 augustus 2019

Primaire voltooiing (Verwacht)

31 december 2019

Studie voltooiing (Verwacht)

31 december 2020

Studieregistratiedata

Eerst ingediend

19 juli 2019

Eerst ingediend dat voldeed aan de QC-criteria

31 juli 2019

Eerst geplaatst (Werkelijk)

2 augustus 2019

Updates van studierecords

Laatste update geplaatst (Werkelijk)

2 augustus 2019

Laatste update ingediend die voldeed aan QC-criteria

31 juli 2019

Laatst geverifieerd

1 juli 2019

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren